Science-Driven • Investor-Backed • Results-Focused

NadiIQ HemoGuard
Heart & Blood
10 Genetic Traits

NadiIQ HemoGuard

Blood Health & Clotting Disorders

Program Overview

10 genetic traits analysed

10 genetic traits — 3 thrombophilia/clotting risks (Factor V Leiden, Prothrombin, VTE) plus 7 lipid metabolism traits (LDL, HDL, cholesterol, triglycerides, homocysteine). Precision haematology from genetic risk to lab validation.

Target Conditions

ThrombophiliaFamilial HypercholesterolemiaAnaemiaIron OverloadDyslipidemia

Who Is This Program For?

Individuals with clotting disorders, familial hypercholesterolemia, chronic anaemia, iron overload, or elevated homocysteine.

Key Outcomes

  • Genetically-informed clotting risk management
  • Know if you carry Factor V Leiden or Prothrombin mutations
  • Optimised lipid levels with targeted protocols
  • Reduced VTE risk with genetic + lab-guided anticoagulation
5-Layer Protocol

How HemoGuard Works

Every NadiIQ program follows our proprietary 5-layer protocol — from genetic decoding to outcome tracking.

Layer 1: Decode

GenomIQ genetic test — your fixed risk blueprint (188 traits)

1
Factor V Leiden-mediated thrombophilia (F5 gene)
2
Prothrombin-mediated thrombophilia (F2 gene)
3
Risk of venous thromboembolism
4
Risk of familial hypercholesterolemia (LDLR)
5
Risk of having high LDL levels (LDLR, APOB)
6
Risk of having high total cholesterol (HMGCR, APOE)
7
Risk of having high triglyceride levels (LPL, APOC2)
8
Risk of having low HDL levels (ABCA1, CETP)
9
Risk of having high homocysteine (MTHFR, MTR)
10
Lipid clearance efficiency → cardiac event risk (APOE)

10 Genetic Traits Decoded

Your one-time GenomIQ test analyses these specific traits for this program

Factor V Leiden-mediated thrombophilia (F5 gene)
Prothrombin-mediated thrombophilia (F2 gene)
Risk of venous thromboembolism
Risk of familial hypercholesterolemia (LDLR)
Risk of having high LDL levels (LDLR, APOB)
Risk of having high total cholesterol (HMGCR, APOE)
Risk of having high triglyceride levels (LPL, APOC2)
Risk of having low HDL levels (ABCA1, CETP)
Risk of having high homocysteine (MTHFR, MTR)
Lipid clearance efficiency → cardiac event risk (APOE)

Diagnostic Tests

In-house lab validation

  • Complete lipid panel
  • Coagulation panel (PT, APTT, D-dimer, fibrinogen)
  • Homocysteine
  • Iron studies (ferritin, TIBC)
  • CBC with differential
  • Vitamin B12, Folate
  • Lp(a)

Ring Monitoring

24/7 real-time via Smart Ring

  • Heart rate trends
  • ECG (rhythm changes)
  • Activity levels (DVT prevention)
  • SpO2
  • Temperature (thrombosis inflammation)

Clinical Interventions

Therapies & treatment protocols

  • Anticoagulant management
  • IV iron therapy (deficiency)
  • Therapeutic phlebotomy (iron overload)
  • Lipid-lowering protocols
  • B12/folate supplementation
  • Movement prescription (DVT prevention)

Outcome Tracking

Measurable progress metrics

  • Coagulation panel retesting
  • Lipid trends quarterly
  • Iron studies monitoring
  • DVT risk scoring

Your Journey with HemoGuard

From genetic test to measurable outcomes

Step 1

Take the GenomIQ Test

Your saliva sample is analysed for 10 genetic traits specific to this program. This is a one-time test — your genetic risk blueprint never changes.

Step 2

Meet Your Care Team

A board-certified physician reviews your genetic report, orders diagnostic labs to validate current status, and designs your personalised protocol.

Step 3

Receive Your Smart Ring

Your NadiIQ Smart Ring begins continuous monitoring — heart rate, HRV, SpO2, temperature, sleep, and activity — filling the gaps between lab visits.

Step 4

Begin Clinical Interventions

Genetically-matched nutrition plans, exercise prescriptions, therapies (HBOT, cryotherapy, IV drips, PRP), and medication optimisation.

Step 5

Track & Optimise

Regular lab retesting, ring data analysis, and care team consultations. Your protocol evolves as your body responds.

Ready to Start Your
HemoGuard Journey?

Get your genetic risk blueprint, meet your care team, and begin your personalised 5-layer protocol.